Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Sareum Share Price
  4. Sareum Share Regulatory News
  5. Additional disclosure concerning Michael Owen

Pin to quick picksSareum Regulatory News (SAR)

Sareum Information

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.25
Bid: 24.00
Ask: 24.50
Change: -1.00 (-3.96%)
Spread: 0.50 (2.083%)
Open: 25.25
High: 25.25
Low: 24.25
Prev. Close: 25.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Additional disclosure concerning Michael Owen

29 Jul 2019 16:29

RNS Number : 0933H
Sareum Holdings PLC
29 July 2019
 

(AIM: SAR)

29 July 2019

 

Sareum Holdings plc

("Sareum" or "the Company")

Additional disclosure concerning Michael Owen

 

Sareum Holdings PLC, the specialist small molecule drug development business, announced on 13 November 2018 the appointment of Michael Owen as a Non-Executive Director of the Company.

It has come to Sareum's attention that whilst his former directorship of BliNK Biomedical SAS ("BliNK") was detailed in that announcement, his former directorship of BliNK's subsidiary Blink Therapeutics Limited during the five years prior to that announcement should also have been included.

 

For further information, please contact: 

Sareum Holdings plc

 

Tim Mitchell

01223 497 700

WH Ireland Limited (Nominated Adviser)

Chris Fielding / James Sinclair-Ford

020 7220 1666

Hybridan LLP (Nominated Broker)

 

Claire Noyce

020 3764 2341

Citigate Dewe Rogerson (Media enquiries)

 

Shabnam Bashir/ Mark Swallow/ David Dible

020 7638 9571

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNEKLFLKDFLBBQ
123456789
Date   Source Headline
20th Oct 20201:00 pmRNSExercise of Share Options and Director Dealings
13th Oct 20207:01 amRNSFull Year Results Investor Presentation
13th Oct 20207:00 amRNSFinal Results
12th Oct 20204:41 pmRNSSecond Price Monitoring Extn
12th Oct 20204:36 pmRNSPrice Monitoring Extension
8th Oct 20207:00 amRNSUS Patent Allowance: SDC-1802 TYK2/JAK1 Inhibitor
12th Aug 20207:00 amRNSDetails of Investor Presentation
11th Aug 20207:00 amRNSTrading Statement
29th Jul 20202:05 pmRNSSecond Price Monitoring Extn
29th Jul 20202:00 pmRNSPrice Monitoring Extension
24th Jul 20207:00 amRNSResearch Update
1st Jul 20207:00 amRNSUpdate on Deferred Salaries and Issue of Equity
3rd Jun 202011:06 amRNSSecond Price Monitoring Extn
3rd Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSSuccessful Fundraising
2nd Jun 20204:31 pmRNSPrimaryBid.com Offer
2nd Jun 20204:30 pmRNSPlacing to raise £718,500
27th May 20207:00 amRNSSareum to Present at BIO Digital 2020
1st May 20207:00 amRNSBioTrinity Presentation Available Online
28th Apr 20207:00 amRNSCompany Presentation at BioTrinity
20th Apr 202011:00 amRNSPrice Monitoring Extension
17th Apr 202011:05 amRNSSecond Price Monitoring Extn
17th Apr 202011:00 amRNSPrice Monitoring Extension
14th Apr 202011:06 amRNSSecond Price Monitoring Extn
14th Apr 202011:01 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSHalf-year Report
26th Mar 20207:00 amRNSGlobal Licensing of FL3+Aurora Programme
12th Mar 20207:00 amRNSPublication: new SRA737 combinations in cancer
17th Dec 20191:36 pmRNSResult of AGM
17th Dec 20197:00 amRNSAGM Statement
20th Nov 20197:00 amRNSNotice of AGM
5th Nov 201910:56 amRNSSareum notes Sierra Oncology Q3 2019 results
30th Oct 20197:00 amRNSResearch Update - SDC-1802 anti-cancer poster
17th Oct 20197:00 amRNSResearch Update - AACR-NCI-EORTC abstract
15th Oct 20197:00 amRNSFinal Results
7th Oct 20197:00 amRNSNotice of Full Year Results
27th Sep 20197:00 amRNSResearch Update - TYK2/JAK1 cancer programme
27th Aug 20197:00 amRNSTrading Statement
16th Aug 20197:00 amRNSChange of Adviser
8th Aug 20192:17 pmRNSSareum notes Sierra Q2 results
29th Jul 20194:29 pmRNSAdditional disclosure concerning Michael Owen
28th Jun 20197:00 amRNSAdditional Funds Raised
27th Jun 20191:50 pmRNSSierra seeks strategic options for SRA737
26th Jun 20197:00 amRNSSuccessful Fundraising
25th Jun 20194:31 pmRNSPrimaryBid.com Offer
25th Jun 20194:30 pmRNSPlacing to progress TYK2/JAK1 programmes
13th Jun 20197:00 amRNSPortfolio Update
3rd Jun 20194:00 pmRNSKey takeaways from SRA737 webcast at ASCO
3rd Jun 201911:05 amRNSSecond Price Monitoring Extn
3rd Jun 201911:00 amRNSPrice Monitoring Extension
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.